Canaan has been a trusted investor in technology and healthcare companies since 1987. Canaan has funded more than 240 companies since inception. With recent investments in the US, Israel, and India, Canaan catalyzes the growth of market leaders globally.
Calibra is developing medical devices and technologies designed to make insulin therapy easier and more discreet.
Private | Redwood City, CA
Calixa is developing hospital-based antibiotics to treat infections resulting from resistant strains of bacteria.
Acquired by Cubist Pharmaceuticals
CapMAC was a leading provider of financial guarantee insurance for structured securities, worldwide.
Public. Merged with MBIA (MBI)
Capstone Turbine is the world leader in microturbines for distributed power generation and co-gen applications.
Public (CPST) | Chatsworth, CA
Cardlytics is developing a powerful, new loyalty solution for banks.
Private | Atlanta, GA
Casabi provides an end-to-end solution for carriers to deliver web-based content or services to cordless phones and other smart devices at home.
Private | Campbell, CA
Cell Pathways is a development-stage pharmaceutical company focused on novel medications to treat and prevent cancer and certain autoimmune diseases.
Public. Acquired by OSI Pharmaceuticals (OSIP)
Cellcast is a leader in the provision of participation television programming and interactive mobile content in the digital entertainment sector.
Private | India
Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.
Public (CNTO) | Malvern, PA
Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections.
Acquired by Forest Labs (FRX)
Chakpak is a leading movie portal in India.
Private | India
Chimerix develops orally-available, highly potent antiviral drugs for life threatening diseases such as smallpox and HIV.
Private | Durham, NC
Coapt’s revolutionary “soft tissue fixation technology” enables surgeons to reliably place and shape soft tissue during reconstructive procedures.
Private | Palo Alto, CA
CoAxia is taking a pioneering approach to acute stroke treatment by developing a catheter that directs more blood flow to the brain through collateral vessels.
Private | Maple Grove, MN
CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals to provide a renewable and previously untapped source of novel drug candidates.
Public (CRXX) | Boston, MA
Command Audio owns and licenses a portfolio of patents critical to the transmission, navigation and playback of stored media.
Private | Redwood Shores, CA
CommerceOne pioneered and brought B2B ecommerce to the masses.
Public (CMRC) | Walnut Creek, CA
Concord Communications was a market leader in automating technology management of the Internet infrastructure.
Public. Acquired by CA Inc.
Copper Mountain technology led the 1990’s DSL wave in North America.
Public. Acquired by Tut Systems (TUTS)
Cortina is a leading supplier of intelligent communication solutions.
Private | Sunnyvale, CA
CrossLogix builds software that entitles Internet access to enterprise applications, content, and data.
Acquired by BEA Systems (BEAS)
Cylex diagnostics have transformed the ability of doctors to measure immune system functioning.
Private | Columbia, MD
Data Sciences International is a pioneer in the field of wireless monitoring and the platform of choice for life science researchers worldwide.
Private | St. Paul, MN
DexCom is tackling the diabetes epidemic by developing sensors that wirelessly transmit glucose readings to patients and theirs doctors.
Public (DXCM) | San Diego, CA
Dexterra is the industry leading mobile application and mobile platform provider.
Acquired by Antenna Software
Diffusion Software develops Intranet and Extranet software for the targeted distribution of business critical information through different media.
Acquired by Vignette (VIGN)
DoubleClick is the leading online advertising solution.
Public (DCLK); Acquired by Google (NASDAQ: GOOG)
Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs.
Private | New York, NY